Gilliland Jeter Wealth Management LLC Has $2.67 Million Position in Intuitive Surgical, Inc. $ISRG

Gilliland Jeter Wealth Management LLC reduced its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 4,909 shares of the medical equipment provider’s stock after selling 61 shares during the quarter. Gilliland Jeter Wealth Management LLC’s holdings in Intuitive Surgical were worth $2,668,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Norway Savings Bank grew its position in shares of Intuitive Surgical by 53.4% during the 2nd quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock worth $1,420,000 after buying an additional 910 shares during the period. IronOak Wealth LLC. acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth about $1,099,000. Trust Co. of Oklahoma acquired a new position in shares of Intuitive Surgical during the 2nd quarter worth about $363,000. Neville Rodie & Shaw Inc. grew its position in shares of Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock valued at $5,666,000 after purchasing an additional 1,110 shares during the period. Finally, Banque Pictet & Cie SA grew its position in shares of Intuitive Surgical by 12.1% in the 2nd quarter. Banque Pictet & Cie SA now owns 37,768 shares of the medical equipment provider’s stock valued at $20,524,000 after purchasing an additional 4,085 shares during the period. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

NASDAQ ISRG opened at $443.76 on Friday. The stock has a market capitalization of $159.08 billion, a price-to-earnings ratio of 61.89, a PEG ratio of 4.71 and a beta of 1.61. The stock’s 50 day moving average price is $459.75 and its two-hundred day moving average price is $498.61. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same quarter in the prior year, the business posted $1.78 EPS. The business’s revenue was up 21.4% compared to the same quarter last year. On average, equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total value of $13,872,306.40. Following the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Amy L. Ladd sold 335 shares of the stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 45,224 shares of company stock worth $21,716,492 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on ISRG shares. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, October 4th. Evercore ISI decreased their price objective on Intuitive Surgical from $535.00 to $450.00 and set an “in-line” rating for the company in a research report on Tuesday. Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. The Goldman Sachs Group decreased their price objective on Intuitive Surgical from $621.00 to $567.00 and set a “buy” rating for the company in a research report on Wednesday, October 1st. Finally, Royal Bank Of Canada reiterated an “outperform” rating and issued a $615.00 price objective on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Fourteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $589.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.